Recommended Dosing of Methylcobalamin for Adults
For adults with vitamin B12 deficiency, oral methylcobalamin should be dosed at 1000 mcg daily, or if parenteral administration is required, 500 mcg intramuscularly three times weekly for 2 weeks followed by maintenance dosing. 1
Oral Administration
For oral supplementation in adults without contraindications:
- Standard oral dose: 1000 mcg/day is required to normalize metabolic markers (methylmalonic acid) in most B12-deficient adults 1
- Lower doses of 25-100 mcg daily are insufficient to normalize methylmalonic acid levels in the majority of deficient patients 1
- This dose exceeds what is available in standard multivitamins and requires dedicated B12 supplementation 1
Important caveat: Oral therapy is only appropriate when absorption is intact. If malabsorption is present (pernicious anemia, gastrectomy, terminal ileal disease), parenteral administration is mandatory 2.
Parenteral Administration
When intramuscular therapy is indicated:
- Loading phase: 500 mcg IM three times weekly for 2 weeks 3
- This regimen produces significantly higher serum cobalamin levels compared to once-weekly dosing 4
- After loading, maintenance varies but typically 1000 mcg every 2 months per British National Formulary guidelines 2
Critical consideration: Up to 50% of patients with malabsorption require individualized, more frequent dosing (ranging from twice weekly to every 2-4 weeks) to remain symptom-free 2. The FDA label for cyanocobalamin notes that pernicious anemia patients require monthly injections for life 5.
Maintenance Requirements
For ongoing supplementation in healthy adults:
- Dietary reference intake: 2.4 mcg/day for maintenance of hematological status 6
- Pregnancy: 5 mcg/day 6
- Lactation: 2.8 mcg/day minimum 6
- Enteral nutrition: 2.5 mcg per 1500 kcal 6
- Parenteral nutrition: 5 mcg/day 6
Key Clinical Pitfalls
Never delay treatment pending test results if clinical features strongly suggest deficiency—irreversible neurological damage can occur within 3 months 5. The most dangerous error is giving folic acid (>0.1 mg/day) to a B12-deficient patient, which corrects anemia but allows neurological deterioration to progress unchecked 5.
Do not use serum B12 levels to titrate injection frequency in patients on maintenance therapy—clinical symptom resolution is the appropriate endpoint 2. Some patients require more frequent injections than standard protocols suggest to maintain quality of life.
Sublingual methylcobalamin at 500 mcg daily (age <8 years) or 1000 mcg daily (age ≥8 years) for 1.5 months, then three times weekly for another 1.5 months, has shown equivalence to intramuscular therapy in pediatric studies 7, though adult data for sublingual routes remain limited and cannot be recommended as replacement for injections in malabsorption 2.
Monitoring
- Assess at least annually with resolution of clinical symptoms and laboratory markers 6
- Initial treatment monitoring: serum potassium in first 48 hours (risk of hypokalemia), then hematocrit and reticulocyte counts daily from days 5-7 until normalized 5
- Screen with combination of at least two biomarkers: holo-transcobalamin and methylmalonic acid, or serum cobalamin as replacement 6